Lung cancer: is there a place for elective nodal irradiation?;Cancers bronchiques : la radiothérapie prophylactique des aires ganglionnaires a-t-elle encore une place ?

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 354-360

  Le Pechoux C ^a   Ferreira, I ^a   Bruna, A ^a   Roberti, E ^a   Besse, B ^a   Bretel, J J ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Conformal radiotherapy; Involved field irradiation; Lung carcinoma; No elective nodal irradiation

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; IRRADIATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; RADIOLOGY; SHORT SURVEY; SURVIVAL RATE; TUMOR VOLUME; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; RADIOGRAPHY; REVIEW;

HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 33750459658     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.09.004     Document Type: Short Survey

References (64)

1. Armstrong J.G., Burman C., Leibel S., Fontenla D., Kutcher G., Zelefsky M., et al. Three dimensional conformal therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 26 (1993) 685-689
2. Arriagada R., Le Chevalier T., Quoix E., Ruffié P., Martin M., Tarayre M., et al. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 1183-1190
3. Arriagada R., Le Chevalier T., Rekacewicz C., et al. Cis-platin based chemotherapy in patients with locally advanced non-small cell lung cancer: late analysis of a French randomized trial. J. Clin. Oncol. 16 (1997) S446
4. Baas P., Belderbos J.S., Senan S., Kwa H.B., van Bochove A., van Tinteren H., et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study. Br. J. Cancer 94 (2006) 625-630
5. Belderbos J.S.A., De Jaeger K., Heemsbergen W.D., Seppenwoolde Y., Baas P., Boersma L.J., et al. Final results of a phase I/II dose-escalation trial in non-small cell lung cancer using 3-dimensional conformal radiotherapy. Radiother. Oncol. 66 (2003) 119-126
6. Bradley J.D., Wahab S., Lockett M.A., Perez C.A., and Purdy J.A. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small cell lung carcinoma treated with limited radiotherapy fields. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 342-347
7. Bradley J., and Movsas B. Radiation esophagitis: predictive factors and preventive strategies. Semin. Radiat. Oncol. 14 (2004) 280-286
8. Bradley J., Graham M.V., Winter K., Purdy J.A., Komaki R., Roa W.H., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 318-328
9. Cerfolio R.J., Bryant A.S., Winokur T.S., Ohja B., and Bartolucci A.A. The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer. Ann. Thorac. Surg. 78 (2004) 1017-1023
10. Chapet O., Kong F.M., Quint L.E., Chang A.C., Ten Haken R.K., Eisbruch A., et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 170-178
11. Chang D.T., Zlotecki R.A., and Olivier K.R. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am. J. Clin. Oncol. 28 (2005) 597-602
12. Chen M., Hayman J.A., Ten Haken R.K., Tatro D., Fernando S., and Kong F.M. Long-term results of high dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 120-126
13. Cheung P.C.F., Mackillop W.J., Dixon P., Brundage M.D., Youssef Y.M., and Zhou S. Involved-Field Radiotherapy alone for early-stage non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 703-710
14. Cox J.D., Azarnia N., Byhardt R.W., Shin K.H., Emami B., and Pajak T.F. A randomized phase I/II trial of hyperfractionated radiation therapy wilh total doses of 60.0 to 79.2 Gy: possible survival benefit with > 69,6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma. Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8 (1990) 1543-1555
15. Curran W., Scott C.B., Langer C.J., Komaki R., Lee J.S., Hauser S., et al. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III nsclc: RTOG 9410. J. Clin. Oncol. 22 (2003) 621 (Abstract)
16. De Ruysscher D., Wanders S., van Haren E., Hochstenbag M., Geeraedts W., Utama I., et al. Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: a prospective clinical study. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 988-994
17. Dwamena B.A., Sonnad S.S., Angobaldo J.O., and Wahl R.L. Metastases from non-small cell lung cancer: mediastinal staging in the 1990's. Metaanalytic comparison of PET and CT. Radiology 213 (1999) 530-536
18. Emami B., Mirkovic N., Scott C., Byhardt R., Graham M.V., James Andras E., et al. The impact of regional nodal radiotherapy (dose-volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer 41 (2003) 207-214
19. Fischer B.M., Mortensen J., and Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol. 2 (2001) 659-666
20. Fournel P., Robinet G., Thomas P., Souquet P.J., Léna H., Vergnenègre A., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. J. Clin. Oncol. 23 (2005) 5910-5917
21. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J. Clin. Oncol. 17 (1999) 2692-2699
22. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg. 60 (1995) 615-622
23. Giraud P., De Rycke Y., Minet P., Danhier S., Dubray B., Helfre S., et al. Estimation de la probabilité d'envahissement tumoral médiastinal: une définition statistique du volume-cible anatomoclinique pour la radiothérapie conformationnelle des cancers bronchiques non à petites cellules?. Cancer Radiother. 6 (2001) 725-736
24. Gould M.K., Kuschner W.G., Rydzak C.E., Maclean C.C., Demas A.N., Shigemitsu H., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. A meta-analysis. Ann. Intern. Med. 139 (2003) 879-892
25. Graeter T.P., Hellwig D., Hoffmann K., Ukena D., Kirsch C.M., and Schafers H.J. Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann. Thorac. Surg. 75 (2003) 231-236
26. Gress F.G., Savides T.J., Sandler A., Kesler K., Conces D., Cummings O., et al. Endoscopic ultrasonography, fine-needle aspiration guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study. Ann. Intern. Med. 127 (1997) 604-612
27. Grills I.S., Yan D., Martinez A.A., Vicini F.A., Wong J.W., and Kestin L.L. Potential for reduced toxicity and dose-escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 875-890
28. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd III R.F., Littles J.F., et al. Dose-escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J. Clin. Oncol. 19 (2001) 127-136
29. Hicks R.J., Kalff V., MacManus M.P., Ware R.E., Hogg A., McKenzie A.F., et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J. Nucl. Med. 42 (2001) 1596-1604
30. Izbicki J.R., Passlick B., Pantel K., et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small-cell lung cancer: results of a prospective randomized trial. Ann. Surg. 227 (1998) 138-144
31. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in non small cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI). Radiother. Oncol. 71 (2004) 123-125
32. Kiricuta I.C., Mueller G., Stiess J., and Bohndorf W. The lymphatic pathways of non-small cell lung cancer and their implication in curative irradiation treatment. Lung Cancer 11 (1994) 74-82
33. Kotoulas C.S., Foroulis C.N., Kostikas K., Konstantinou M., Kalkandi P., Dimadi M., et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer according to the primary cancer location. Lung Cancer 44 (2004) 183-191
34. Krol A.D., Aussems P., Noordijk E.M., Hermans J., and Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int. J. Radiat. Oncol. Biol. Phys. 34 (1996) 297-302
35. Liengswangwong V., and Bonner J.A. Point: the potential importance of elective nodal irradiation in the treatment of non-small-cell lung cancer. Semin. Radiat. Oncol. 10 (2000) 308-314
36. McGibney C., Holmberg O., McClean B., Williams C., McCrea P., Sutton P., et al. Dose-escalation of CHART in non-small-cell lung cancer: is three-dimensional conformal radiation therapy really necessary?. Int. J. Radiat. Oncol. Biol. Phys. 45 (1999) 339-350
37. Mac Manus M.P., Hicks R.J., Ball D.L., Kalff V., Matthews J.P., Salminen E., et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 287-293
38. Martel M.K., Ten Haken R.K., Hazuka M.B., Kessler M.L., Strawderman M., Turrisi A.T., et al. Estimation of tumor control probability model parameters from 3D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
39. Maruyama R., Sugio K., Mitsudomi T., Saitoh G., Ishida T., and Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 114 (1997) 535-543
40. Maddaus M.A., Wang X., Vollmer R.T., Abraham N.Z., D'Cunha J., Herzan H.L., et al. CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC. J. Clin. Oncol. 24 (2006) 371S
41. Miller K.L., Shafman T.D., and Marks L.B. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin. Radiat. Oncol. 14 (2004) 298-307
42. Mountain C.F. A new international staging system for lung cancer. Chest 89 (1986) 225S-233S
43. Mountain C.F. Revisions in the International System for staging lung cancer. Chest 117 (1997) 1710-1717
44. Non-Small-Cell Lung Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311 (1995) 899-909
45. Noordijk E.M., vd Poest Clement E., Hermans J., Wever A.M., and Leer J.W. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother. Oncol. 13 (1988) 83-89
46. Oda M., Watanabe Y., Shimizu J., Murakami S., Ohta Y., Sekido N., et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer. Lung Cancer 22 (1998) 23-30
47. Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small-cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
48. Passlick B., Izbicki J.R., Kubuschok B., Thetter O., and Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann. Thorac. Surg. 61 (1996) 177-183
49. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koëter G.H., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343 (2000) 254-261
50. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev. Epidemiol. Sante Publique 51 (2003) 3-30
51. Roberts P.F., Follette D.M., von Haag D., Park J.A., Valk P.E., Pounds T.R., et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann. Thorac. Surg. 70 (2000) 1154-1159
52. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., and Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 681-685
53. Rowell N.P., and Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). The Cochrane Database of Systematic Reviews Issue 2 (2001) 1-28
54. Sibley G.S., Jamieson T.A., Marks L.B., Anscher M.S., and Prosnitz L.R. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer : the Duke Experience. Int. J. Radiat. Oncol. Biol. Phys. 40 (1998) 149-154
55. Senan S., Burgers S., Samson M.J., van Klaveren R.J., Oei S.S., van Sornsen de Koste J., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 999-1006
56. Senan S., De Ruysscher D., Giraud P., Mirimanoff R., Budach V., and Radiotherapy Group of European Organization for Research and Treatment of Cancer. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother. Oncol. 71 (2004) 139-146
57. Senan S., and De Ruysscher D. Critical review of PET-CT for radiotherapy planning in lung cancer. Crit. Rev. Oncol. Hematol. 56 (2005) 345-351
58. Slotman B.J., Njo K.H., and Karim A.B.M.F. Curative radiotherapy for technically operable stage I non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 29 (1994) 33-37
59. Socinski M.A., Morris D.E., Halle J.S., Moore D.T., Hensing T.A., Limentani S.A., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable Stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J. Clin. Oncol. 22 (2004) 4341-4350
60. van Der Wel A., Nijsten S., Hochstenbag M., Lamers R., Boersma L., Wanders R., et al. Increased therapeutic ratio by 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small-cell lung cancer (NSCLC): a modelling study. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 648-654
61. Viney R.C., Boyer M.J., King M.T., Kenny P.M., Pollicino C.A., McLean J.M., et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J. Clin. Oncol. 22 (2004) 2357-2362
62. Watanabe Y., Shimizu J., Tsubota M., and Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer. Chest 97 (1990) 1059-1065
63. Williams T.E., Thomas C.R., and Turrisi A.T. Counterpoint: better radiation treatment of NSCLC using new techniques without elective nodal irradiation. Semin. Radiat. Oncol. 10 (2000) 315-323
64. Wu Y., Huang Z.F., Wang S.Y., Yang X.N., and Ou W. A randomized trial of systematic nodal dissection in resectable non-small-cell lung cancer. Lung Cancer 36 (2002) 1-6